Vascular access: Issues and management

Contributions to Nephrology

Volumn 142, Issue , 2004, Pages 29-46

  Besarab, Anatole ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS SHUNT; BLOOD FLOW VELOCITY; CHRONIC KIDNEY FAILURE; FEMALE; GRAFT SURVIVAL; HUMAN; INDWELLING CATHETER; MALE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; STANDARD; TOTAL QUALITY MANAGEMENT; UNITED STATES; VASCULAR PATENCY;

ARTERIOVENOUS SHUNT, SURGICAL; BLOOD FLOW VELOCITY; CATHETERS, INDWELLING; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PATIENT CARE TEAM; RENAL DIALYSIS; RISK ASSESSMENT; TOTAL QUALITY MANAGEMENT; UNITED STATES; VASCULAR PATENCY;

EID: 1342311428     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (128)

1. US Renal Data System, USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
2. USRD 1997 Annual Data Report. X. Am J Kidney Dis 1997;30(suppl 2):S160-S177.
3. Rocco MV, Bleyer AJ, Burkart JM: Utilization of inpatient and outpatient resources for the management of hemodialysis access complications. Am J Kidney Dis 1996;28/2:250-256.
4. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. Am Soc Nephrol 1996;7:523-535.
5. Lazarus JM, Huang WH, Lew NL, Lowrie EG: Contribution of vascular access-related disease to morbidity of hemodialysis; in Henry ML, Ferguson RM (eds): Vascular Access for Hemodialysis III. Chicago, Gore & Associates and Precept Press, 1993, pp 23-42.
6. Ascher E, Gade P, Hingorani A, Mazzariol F, Gunduz Y, Fodera M, Yorkovich W: Changes in the practice of angioaccess surgery: Impact of dialysis outcome and quality initiative recommendations. J Vasc Surg 2000;1/1:84-92.
7. Bosch JP, Walters BA: Quality assurance and continuous quality improvement in the management of vascular access. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 60-99.
8. Collins AJ, Roberts TL, St Peter WL, Chen SC, Ebben J, Constantini E: United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines. Am J Kidney Dis 2002;39:784-795.
9. van Andringa de Kempenaer T, ten Have P, Oskam J: Improving quality of vascular access care for hemodialysis patients. Jt Comm J Qual Saf 2003;29:191-198.
10. NKF-DOQI Clinical Practice Guidelines for Vascular Access. New York, National Kidney Foundation, 1997.
11. Eknoyan G, Levin NW: Impact of the new K/DOQI guidelines. Blood Purif 2002;20:103-108.
12. National Kidney Foundation K/DOQI clinical practice guidelines for vascular access, 2000. Am J Kidney Dis 2001;37(suppl 1):S137-S181.
13. Eknoyan G, Levin NW, Steinberg EP: The dialysis outcomes quality initiative: History, impact, and prospects. Am J Kidney Dis 2000;35/4(suppl 1):S69-S75.
14. Health Care Financing Administration. Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Baltimore, Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, 2002.
15. Beathard GA: Improving dialysis vascular access. Dialysis Transplant 2002;31:210-217.
16. Tokars JI, Alter MJ, Arduino MJ: National Surveillance of Dialysis-Associated Diseases in the United States, 2000. Atlanta, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, Department of Health and Human Services, 2001.
17. Ifudu O, Macey LJ, Homel P, et al: Determinants of type of initial hemodialysis vascular access. Am J Nephrol 1997;17:425-427.
18. Hakim RA, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994;23:661-669.
19. Atherikul K, Schwab SJ, Conlon PJ: Adequacy of haemodialysis with cuffed central-vein catheters. Nephrol Dial Transplant 1998;13:745-749.
20. Konner K: Increasing the proportion of diabetics with AV fistulas. Semin Dial 2001;14:1-4.
21. Wedgewood KR, Wiggins PA, Guillou PJ: A prospective study of end-to-end vs. side-to-side arteriovenous fistulas for haemodialysis. Br J Surg 1984;71:640-642.
22. Begin V, Ethier J, Dumont M, Leblanc M: Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae. Am J Kidney Dis 2002;40:1277-1282.
23. Johnson CP, Zhu YR, Matt C, Pelz C, Roza AM, Adams MB: Prognostic value of intraoperative blood flow measurements in vascular access surgery. Surgery 1998;124:729-738.
24. Bosman PJ, Boereboom FT, Bakker CJ, Mali WP, Eikelboom BC, Blankestijn PJ, Koomans HA: Access flow measurements in hemodialysis patients: In vivo validation of an ultrasound dilution technique. J Am Soc Nephrol 1996;7:966-969.
25. Besarab A, Lubkowski T, Vu A, Aslam M, Frinak S: Effects of systemic hemodynamics on flow within vascular accesses used for hemodialysis. ASAIO J 2001;47:501-506.
26. Besarab A, Lubkowski T, Ahsan M, Lim T, Frinak S: Access flow (QA) as a predictor of access dysfunction (abstract). J Am Soc Nephrol 1999; 11:202A.
27. Beathard GA: Catheter thrombosis. Semin Dial 2001;14:441-445.
28. Work J: Hemodialysis catheters and ports. Semin Nephrol 2002;22:211-220.
29. Canaud B, Leray-Moragues H, Kerkeni N, Bosc JY, Martin K: Effective flow performances and dialysis doses delivered with permanent catheters: A 24-month comparative study of permanent catheters versus arteriovenous vascular accesses. Nephrol Dial Transplant 2002;17:1286-1292.
30. Garland JS, Moist LM, Lindsay RM: Are hemodialysis access flow measurements by ultrasound dilution the standard of care for access surveillance? Adv Ren Replace Ther 2002;9:91-98.
31. Polaschegg HD, Sodemann K, Feldmer B: Enhancing patency, safety and cost effectiveness of catheters. EDTNA ERCA J 2002;28:28-32.
32. Francos GC, Burke JF, Besarab A, Martinez J, Kirkwood RG, Hummel LA: An unsuspected cause of acute hemolysis during hemodialysis. ASAIO Trans 1983;29:140-146.
33. Kameneva MV, Marad PF, Brugger JM, Repko BM, Wang JH, Moran J, Borovetz HS: In vitro evaluation of hemolysis and sublethal blood trauma in a novel subcutaneous vascular access system for hemodialysis. ASAIO J 2002;48/1:34-38.
34. Kinnaert P, Vereerstraeten P, Toussaint C, Van Geertruyden J: Nine years' experience with internal arteriovenous fistulas for hemodialysis: Study of some factors influencing results. Br J Surg 1977;64:242-246.
35. Mehta S: Statistical summary of clinical results of vascular access procedures for hemodialysis; in Sommer BG, Henry ML (eds): Vascular Access for Hemodialysis. Chicago, Gore & Associates and Precept Press, 1991, pp 145-157.
36. Brescio MJ, Cimino JE, Appel K, et al: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966;275:1089-1092.
37. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JE: Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-1096.
38. Eggers P, Milam R: Trends in vascular access procedures and expenditures in Medicare's ESRD program; in Henry ML (ed): Vascular Access for Hemodialysis. Part VII. Chicago, Gore & Associates, 2001, pp 133-143.
39. Nassar GM, Ayus JC: Infectious complications of the hemodialysis access. Kidney Int 2001;60:1-13.
40. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in US hemodialysis patients. Kidney Int 2001;60:1443-1451.
41. Sands J, Perry M: Where are all the AV fistulas? Semin Dial 2002;15:146-148.
42. Stevenson KB, Hannah KL, Lowder CA, et al: Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 2002;39:549-555.
43. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C: Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 2002;40:611-622.
44. Woods JD, Port FK: The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant 1997;12:657-659.
45. Anel RL, Yevzlin AS, Ivanovich P: Vascular access and patient outcomes in hemodialysis: Questions answered in recent literature. Artif Organs 2003;27:237-241.
46. Besarab A: Vascular access in Europe and the United States: Striking contrasts. Contemp Dial Nephrol 1999;20:22-28.
47. Hakim R, Himmelfarb J: Hemodialysis access failure: A call to action. Kidney Int 1998;54:1029-1040.
48. Gibson KD, Caps MT, Kohler TR, Hatsukami TS, Gillen DL, Aldassy M, Sherrard DJ, Stehman-Breen C: Assessment of a policy to reduce placement of prosthetic hemodialysis access. Kidney Int 2001;59:2335-2345.
49. Nguyen VD, Griffith C, Robinson KD: Graft free hemodialysis (HD) practice is achievable despite high patient co-morbid factors in a community based dialysis program (abstract). J Am Soc Nephrol 2001;12:299a.
50. Tokars JI, Arduino MJ, Alter MJ: Infection control in hemodialysis units. Infect Dis Clin North Am 2001;15:797-812.
51. Goodkin DA, Mapes DL, Held PJ: The Dialysis Outcomes and Practice Patterns Study (DOPPS): How can we improve the care of hemodialysis patients? Semin Dial 2001;14:157-159.
52. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002;61:305-316.
53. Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, Saito A, Young EW, Port FK: Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003;63:323-330.
54. Allon M, Bailey R, Ballard R, Deierhoi MH, Hamrick K, Oser R, Rhynes VK, Robbin ML, Saddekni S, Zeigler ST: A multidisciplinary approach to hemodialysis access: Prospective evaluation. Kidney Int 1998;53:473-479.
55. Huber TS, Seeger JM: Approach to patients with 'complex' hemodialysis access problems. Semin Dial 2003;16:22-29.
56. Mendes RR, Farber MA, Marston WA, Dinwiddie LC, Keagy BA, Burnham SJ: Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography. J Vasc Surg 2002;36:460-463.
57. Berman SS, Gentile AT: Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance. J Vasc Surg 2001;34:866-871.
58. Murphy GJ, Nicholson ML: Autogeneous elbow fistulas: The effect of diabetes mellitus on maturation, patency, and complication rates. Eur J Vasc Endovasc Surg 2002;23:452-457.
59. Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions. Kidney Int 2002;62:1109-1124.
60. Fan P-Y, Schwab SJ: Vascular access: Concepts for the 1990s. J Am Soc Nephrol 1992;3:1-11.
61. Besarab A, Adams M, Amatucci S, Bowe D, Deane J, Ketchen K, Reynolds K, Tello A: Unraveling the realities of vascular access: The network 11 experience. Adv Ren Replace Ther 2000;4(suppl 1):S65-S70.
62. Lemson MS, Leunissen KML, Tordoir JGM: Does pre-operative duplex examination improve patency rates of Brescia-Climino fistulas? Nephrol Dial Transplant 1998;13:1360-1361.
63. Sedlacek M, Teodorescu V, Falk A, Vassolotti JA, Uribarri J: Hemodialysis access placement with pre-operative noninvasive vascular mapping: Comparison between patients with and without diabetes. Am J Kidney Dis 2001;38:560-564.
64. Ascher E, Hingoran A, Gunduz Y, Yorkovich Y, Ward M, Miranda J, Tsemekhin B, Kleiner M, Greenberg S: The value and limitations of the arm cephalic and basilic vein for arteriovenous access. Ann Vasc Surg 2001;15:89-97.
65. Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, Deierhoi MH, Robbin ML: Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 2001;60:2013-2020.
66. Dalman RL, Harris EJ Jr, Victor BJ, Coogan SM: Transition to all-autogenous hemodialysis access: The role of preoperative vein mapping. Ann Vasc Surg 2002;16:624-630.
67. Vassalotti JA, Falk A, Cohl ED, Uribarri J, Teodorescu V: Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clin Nephrol 2002;58:211-214.
68. 2 and gadopetetate dimeglumine as alternative contrasts for malfunctioning dialysis grafts and fistulas. Kidney Int 1998;54:945-950.
69. Waldman GJ, Pattynama PM, Chang PC, Verburgh C, Reiber JH, de Roos A: Magnetic resonance angiography of dialysis access shunts: Initial results. Magn Reson Imaging 1996;14:197-200.
70. Astor BC, Eustace MB, Powe NR, Klag MJ, Sadler JJH, Fink NE, Coresh J: Timing of nephrologist referral and arteriovenous use: The CHOICE study. Am J Kidney Dis 2001;38:494-501.
71. Silva MB Jr, Hobson RW, Pappas PJ, Jamil Z, Araki CT, Goldberg MC, Gwertzman G, Padberg FT Jr: A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. J Vasc Surg 1998;27:302-308.
72. Bender MH, Bruyinckx CM, Gerlag PG: The brachiocephalic elbow fistula: A useful alternative angioaccess for permanent hemodialysis. J Vasc Surg 1994;20:808-813.
73. Gade J, Aabech J, Hansen RI: The upper arm arteriovenous fistula - An alternative for vascular access in haemodialysis. Scand J Urol Nephrol 1995;29:121-124.
74. Lindner J: Transposition of the basilic vein in the arm for vascular access in hemodialysis. Rozhl Chir 1997;76:126-128.
75. Polo JR, Vázquez R, Polo J, Sanabia J, Rueda J, Lopez-Baena JA: Brachiocephalic jump graft fistula. An alternative for dialysis use of elbow crease veins. Am J Kidney Dis 1999;33:904-909.
76. Paterson P: Fistula cannulation: The buttonhole technique. Nephrol Nurs J 2002;29:195.
77. Stansfield G: Cannulation of arteriovenous fistulae. Nurs Times 1987;83:38-39.
78. Hurlbert SN, Mattos MA, Henretta JP, Ramsey DE, Barkmeier LD, Hodgson KJ, Summer DS: Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: A prospective study that compares Impra versus Goretex grafts. Cardiovasc Surg 1998;6:652-656.
79. Kaufman JL, Garb JL, Berman JA, Rhee SW, Norris MA, Friedmann P: A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: Does the manufacturer matter? J Am Coll Surg 1997;185:74-79.
80. Almonacid PJ, Pallares EC, Rodriguez AQ, Valdes JS, Rueda Orgaz JA, Polo JR: Comparative study of use of Diastat versus standard wall PTFE grafts in upper arm hemodialysis access. Ann Vasc Surg 2000;14:659-662.
81. Lenz BJ, Veldenz HC, Dennis JW, Khansarinia S, Atteberry LR: A three-year follow-up on standard versus thin wall ePTFE grafts for hemodialysis. J Vasc Surg 1998;28:464-470.
82. Allen RD, Yuill E, Nankivell BJ, Francis DM: Australian multicentre evaluation of a new Polyurethane vascular access graft. Aust NZ J Surg 1996;66:738-742.
83. Bolton WD, Cull DL, Taylor SM, Carsten CG 3rd, Snyder BA, Sullivan TM, Youkey JR, Langan EM 3rd, Gray BH: The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: A word of caution. J Vasc Surg 2002;36:464-468.
84. Matsuura JH, Johansen KH, Rosenthal D, Clark MD, Clarke KA, Kirby LB: Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg 2000;14:50-55.
85. Nakao A, Miyazaki M, Oka Y, Matsuda H, Oishi M, Kokumai Y, Kunitomo K, Isozaki H, Tanaka N: Creation and use of a composite polyurethane-expanded polytetrafluoroethylene graft for hemodialysis access. Acta Med Okayama 2000;54:91-94.
86. Skandalos I, Chatzibaloglou A, Tsalis K, Tourlis T, Kalpakidis V, Anagnostopoulos T, Dadoukis I, Sombolos K: Prosthetic graft placement using the deep forearm veins in hemodialysis patients: A preliminary report. Nephron 2000;85:346-347.
87. Won T, Min SK, Jang JW, Choi SH, Choi KB, Han JJ, Ahn JH: Early result of arteriovenous graft with deep forearm veins as an outflow in hemodialysis patients. Ann Vasc Surg 2002;16:501-504.
88. Lemson MS, Leunissen KML, Tordoir JGM: Does pre-operative duplex examination improve patency rates of Brescia-Climino fistulas? Nephrol Dial Transplant 1998;13:1360-1361.
89. Sorom AJ, Hughes CB, McCarthy JT, Jenson BM, Prieto M, Panneton JM, Sterioff S, Stegall MD, Nyberg SL: Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery 2002;132:135-140.
90. Leypoldt JK: Diagnostic methods for vascular access: Access flow measurements. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 31-37.
91. Besarab A, Lubkowski T, Frinak S: A simpler method for measuring intra-access pressure (abstract). J Am Soc Nephrol 1999;11:202A.
92. Frinak S, Zasuwa G, Dunfee T, Besarab A, Yee J: Dynamic venous access pressure ratio test for hemodialysis access monitoring. Am J Kidney Dis 2002;40:760-768.
93. Besarab A, Samarapungavan D: Measuring the adequacy of hemodialysis access. Curr Opin Nephrol Hypertens 1996;5:527-531.
94. Magnasco A, Alloatti S, Martinoli C, Solari P: Glucose pump test: A new method for blood flow measurements. Nephrol Dial Transplant 2002;17:2244-2248.
95. Ronco C, Brendolan A, Crepaldi C, D'Intini V, Sergeyeva O, Levin NW: Noninvasive transcutaneous access flow measurement before and after hemodialysis: Impact of hematocrit and blood pressure. Blood Purif 2002;20:376-379.
96. Garland JS, Moist LM, Lindsay RM: Are hemodialysis access flow measurements by ultrasound dilution the standard of care for access surveillance? Adv Ren Replace Ther 2002;9:91-98.
97. Besarab A, Frinak S, Aslam M: Pressure measurements in the surveillance of vascular accesses; in Gray R (ed): A Multidisciplinary Approach for Hemodialysis Access. Philadelphia, Lippincott, Williams, & Wilkins, 2002, chap 21, pp 137-150.
98. Cayco AV, Abu-Alfa AK, Mahnensmith RL, Perazella MA: Reduction in arteriovenous graft impairment: Results of a vascular access surveillance protocol. Am J Kidney Dis 1998;32:302-308.
99. Bosman PJ, Boereboom FT, Smits HF, Eikelboom BC, Koomans HA, Blankestijn PJ: Pressure or flow recordings for the surveillance of hemodialysis grafts. Kidney Int 1997;52:1084-1088.
100. McCarley P, Wingard RL, Shyr Y, Pettus W, Hakim RM, Ikizler TA: Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int 2001;60:1164-1172.
101. Besarab A, Sullivan KL, Ross RP, Moritz MJ: Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int 1995;47:1364-1373.
102. Paulson WD, Ram SJ, Work J: Access blood flow: Debate continues. Semin Dial 2001;14:459-460.
103. Krivitski N, Gantela S: Access blood flow: Debate continues. Semin Dial 2001;14:460-461.
104. Besarab A, Lubkowski T, Ahsan M, Lim T, Frinak S: Access flow (QA) as a predictor of access dysfunction (abstract). J Am Soc Nephrol 1999;11:202A.
105. Besarab A, Frinak S: Strategies for prospective detection of graft dysfunction; in Schwab S, Conlon P, Nicholson M. (eds): Hemodialysis Vascular Access. Oxford, Oxford University Press, 2000, pp 157-182.
106. Besarab A, Lubkowski T, Frinak S, Ramanathan S, Escobar F: Detection of strictures and vascular outlet stenoses in vascular accesses: Which test is best? ASAIO J 1997;43:M543-M547.
107. Besarab A, Lubkowski T, Frinak S, Ramanathan S, Escobar F: Detecting vascular access dysfunction. ASAIO J 1997;43:M539-M543.
108. Joseph S, Adler S: Vascular access problems in dialysis patients. Heart Dis 2001;3:242-247.
109. Beathard GA, Marston WA: Endovascular management of thrombosed dialysis access grafts. Am J Kidney Dis 1998;32:172-175.
110. Cooper SG: Original report. Pulse-spray thrombolysis of thrombosed hemodialysis grafts with tissue plasminogen activator. AJR Am J Roentgenol 2003;180:1063-1066.
111. Surlan M, Popovic P: The role of interventional radiology in management of patients with endstage renal disease. Eur J Radiol 2003;46:96-114.
112. Turmel-Rodrigues L, Pengloan J, Bourquelot P: Interventional radiology in hemodialysis fistulae and grafts: A multidisciplinary approach. Cardiovasc Intervent Radiol 2002;25:3-16.
113. Beathard GA: Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts: A controlled study. Kidney Int 1994;45:1401-1406.
114. Bookstein JJ, Bookstein FL: Augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude. J Vasc Interv Radiol 2000;11:299-303.
115. Falk A, Mitty H, Guller J, Teadorescu V, Uribarri J, Vassalotti J: Thrombolysis of clotted hemodialysis grafts with tissue-type plasminogen activator. J Vasc Interv Radiol 2001;12:305-311.
116. Falk A, Guller J, Nowakowski FS, et al: Reteplase in the treatment of thrombosed hemodialysis grafts. J Vasc Interv Radiol 2001;12:1257-1262.
117. Aruny JE, Lewis CA, Cardella JF, Cole PE, Davis A, Drooz AT, Grassi CJ, Gray RJ, Husted JW, Jones MT, McCowan TC, Meranze SG, Van Moore A, Neithamer CD, Oglevie SB, Omary RA, Patel NH, Rholl KS, Roberts AC, Sacks D, Sanchez O, Silverstein MI, Singh H, Swan TL, Towbin RB, et al: Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 1999;10:491-498.
118. Schmitz-Rode T, Wildberger JE, Hubner D, Wein B, Schurmann K, Gunther RW: Recanalization of thrombosed dialysis access with use of a rotating mini-pigtail catheter: Follow-up study. J Vasc Interv Radiol 2000;11:721-727.
119. Vesely TM: Endovascular intervention for the failing vascular access. Adv Ren Replace Ther 2002;9:99-108.
120. Whitman ED: Complications associated with the use of central venous access devices. Curr Probl Surg 1996;33:319-378.
121. Deitcher SR, Fesen MR, Kiproff PM, et al: Safety and efficacy of alteplase for restoring function in occluded central venous catheters: Results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol 2002;20:317-324.
122. Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER; COOL Investigators: Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices. J Vasc Interv Radiol 2001;12:951-955.
123. Haire WD, Atkinson JB, Stephens L, Kotulal G: Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial. Thromb Haemost 1994;72:543-547.
124. Eyrich H, Walton T, Macon EJ, Howe A: Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis. Am J Health Syst Pharm 2002;59:1437-1440.
125. Waterhouse D: Vascular access: A role for a renal nurse clinician. EDTNA ERCA J 2002;28/2:64-69.
126. Wofford S: Care and maintenance of hemodialysis catheters and subcutaneous vascular access devices - A nurse's perspective. Nephrol News Issues 2002;16/9:27-31.
127. Spergel LM: Vascular access: New approaches needed for a more complex ESRD population. Nephrol News Issues 1997;11/2:30-34.
128. Welch KA, Pflederer TA, Knudsen J, Hocking MK: Establishing the vascular access coordinator: Breaking ground for better outcomes. Nephrol News Issues 1998;12/11:43-46.